Although the etiology of Alzheimer's disease (AD) is not fully understood, multiple lines of
evidence suggests the importance of amyloid-β (Aβ) in the initiation/progression of the …

Background Several studies indicated that Erythropoietin (Epo) may provide remarkable
neuroprotection in some neurological diseases. It also showed the significant decrease of …

Background and Purpose Erythropoietin (EPO) exerts neuroprotective actions in the CNS,
including protection against apoptosis induced by the amyloid β− peptide Aβ 25–35 …

Erythropoietin (EPO), a haematopoietic growth factor has been reported to display
neuroprotective properties in different animal models. In the present study, we investigated …

Amyloid beta (Aβ) is a key molecule in the neurodegenerative progression of Alzheimer׳ s
disease (AD). It is critical to develop a treatment that can arrest the Aβ-induced pathologic …

Erythropoietin (EPO) prevents neuronal cell death through the activation of cell survival
signals and the inhibition of apoptotic signals in models of neurodegenerative diseases …

The aim of this study was to explore the neuroprotective effect and the underlying
mechanism of erythropoietin (EPO) on the cortical neuronal cells insulted with oxygen and …

Even though erythropoietin (EPO) is a neurotropic cytokine that is recognized widely for its
role in the development, maintenance, protection, and repair of the nervous system, there …

No longer considered exclusive for the function of the hematopoietic system, erythropoietin
(EPO) is now considered as a viable agent to address central nervous system injury in a …

Neuronal apoptosis is one of the pathological features of Alzheimer's disease (AD).
Morphological pathology reveals that neuronal apoptosis is associated with senile plaques …